Related Experiment Video
Updated: Jan 28, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients
Nourhan M El Samaloty1, Zeinab A Hassan2, Zeinab M Hefny3
1Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Future University, Egypt.
Background And Study Aim:
Hepatitis C represents a potential public health problem worldwide. Insulin resistance (IR) and type 2 diabetes (T2D) are among the serious metabolic complications for chronic hepatitis C virus (HCV) infection. MicroRNAs (miRNAs) are a group of small non-coding RNAs which are implicated in the modulation of almost all biological processes. The objective of this study was to investigate the levels of both miR-155 and miR-34a in sera of chronic HCV patients with or without T2D.
Patients And Methods:
In this study, we investigated the expression of both miR-155 and miR-34a in 80 subjects (20 HCV, 19 HCV/T2D, 21 T2D and 19 healthy controls), using quantitative real-time PCR.
Results:
Our results revealed significantly higher levels of both miR-155 and miR-34a in chronic HCV patients compared to healthy control subjects. However, only circulating miR-155 levels showed significant decline in diabetic HCV patients compared to non-diabetic HCV group. Intriguingly, the circulating levels of miR-155 were inversely correlated with HOMA-IR, fasting blood glucose and HbA1c levels.
Conclusion:
Our findings indicate that the insulin resistance and T2D in HCV are strongly related to miR-155. This may suggest a role for miR-155 in the pathogenesis of IR caused by HCV. However, further large-scale studies are required to confirm our findings.
Insights
Hepatitis C virus (HCV) infection is linked to insulin resistance (IR) and type 2 diabetes (T2D). This study found higher miR-155 levels in HCV patients, which decreased with diabetes and correlated with IR markers.
Area of Science:
- Hepatology
- Endocrinology
- Molecular Biology
Background:
- Chronic Hepatitis C virus (HCV) infection poses a global health challenge.
- Insulin resistance (IR) and type 2 diabetes (T2D) are significant metabolic complications associated with chronic HCV.
- MicroRNAs (miRNAs) are key regulators of biological processes, including metabolic functions.
Purpose of the Study:
- To investigate serum levels of miR-155 and miR-34a in chronic HCV patients.
- To compare miRNA levels in HCV patients with and without type 2 diabetes (T2D).
Main Methods:
- Quantitative real-time PCR was used to measure miR-155 and miR-34a expression.
- The study included 80 participants: HCV patients, HCV/T2D patients, T2D patients, and healthy controls.
Main Results:
- Both miR-155 and miR-34a were significantly elevated in chronic HCV patients compared to controls.
- Circulating miR-155 levels were significantly lower in HCV patients with T2D compared to those without.
- miR-155 levels showed an inverse correlation with HOMA-IR, fasting blood glucose, and HbA1c.
Conclusions:
- miR-155 is strongly associated with insulin resistance and T2D in the context of HCV infection.
- These findings suggest a potential role for miR-155 in the pathogenesis of HCV-induced IR.
- Further large-scale studies are warranted to validate these results.
Related Concept Videos
MicroRNAs
MicroRNAs
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Insulin Secretory Vesicles
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

